Latest / The Founder's Journey with Fexingo: First-Time Entrepreneurs, Failures, and Lessons Learned
The Founder Who Turned a Rejected Science Fair Project Into a 55M Biotech
In this episode, Lucas and Luna tell the story of Dr. Priya Nair, whose high school science fair project on enzyme-coated nanoparticles was rejected by every competition she entered. Years later, that same concept became the foundation for Enzolve Therapeutics, a biotech company valued at $55 million that is now in Phase 2 trials for a targeted cancer therapy. The hosts explore the specific rejection that nearly killed the idea, the moment a grad school professor rediscovered it in a forgotten lab notebook, and the crucial decision to license the technology rather than sell it outright. They…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.